-
1 Comment
Medpace Holdings, Inc is currently in a long term uptrend where the price is trading 19.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.9.
Medpace Holdings, Inc's total revenue rose by 13.0% to $260M since the same quarter in the previous year.
Its net income has increased by 70.6% to $51M since the same quarter in the previous year.
Finally, its free cash flow grew by 90.9% to $98M since the same quarter in the previous year.
Based on the above factors, Medpace Holdings, Inc gets an overall score of 5/5.
CurrencyCode | USD |
---|---|
Exchange | NASDAQ |
ISIN | US58506Q1094 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Dividend Yield | 0.0% |
---|---|
Target Price | 210.33 |
PE Ratio | 26.98 |
Market Cap | 6B |
Beta | 1.42 |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MEDP using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024